Terms: = Prostate cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
319 results:
1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract] [Full Text] [Related]
2. A cross-sectional study of ERG expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda.
Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
[TBL] [Abstract] [Full Text] [Related]
3. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators
Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
[TBL] [Abstract] [Full Text] [Related]
4. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators
Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
[TBL] [Abstract] [Full Text] [Related]
6. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators
Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical prostatectomy in Contemporary National Surgical Quality Improvement Program Data.
Homer A; Golijanin B; Schmitt P; Bhatt V; Pareek G; Hyams ES
J Endourol; 2024 Mar; 38(3):270-275. PubMed ID: 38251639
[No Abstract] [Full Text] [Related]
8. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
9. Multimorbidity clusters in adults 50 years or older with and without a history of cancer: National Health Interview Survey, 2018.
Plasencia G; Gray SC; Hall IJ; Smith JL
BMC Geriatr; 2024 Jan; 24(1):50. PubMed ID: 38212690
[TBL] [Abstract] [Full Text] [Related]
10. Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
Filipas DK; Labban M; Beatrici E; Stone BV; Qian Z; D Andrea V; Ludwig TA; Reis LO; Cole AP; Trinh QD
Vaccine; 2024 Jan; 42(3):441-447. PubMed ID: 38184391
[TBL] [Abstract] [Full Text] [Related]
11. The levels and trends of cancer incidence in the elderly population at national and sub-national scales in Iran from 1990 to 2016.
Shokri Varniab Z; Saeedi Moghaddam S; Pourabhari Langroudi A; Azadnajafabad S; Mortazavi SS; Sheidaei A; Gohari K; Farzi Y; Shirzad Moghaddam Z; Sohrabi H; Shati M
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1937. PubMed ID: 38049962
[TBL] [Abstract] [Full Text] [Related]
12. Differences in overall survival of penile cancer patients versus population-based controls.
Scheipner L; Tappero S; Piccinelli ML; Barletta F; Garcia CC; Incesu RB; Morra S; Tian Z; Saad F; Shariat SF; Terrone C; De Cobelli O; Briganti A; Chun FKH; Tilki D; Longo N; Seles M; Ahyai S; Karakiewicz PI
Int J Urol; 2024 Mar; 31(3):274-279. PubMed ID: 38014575
[TBL] [Abstract] [Full Text] [Related]
13. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa.
Jalloh M; Cassell A; Niang L; Rebbeck T
BJU Int; 2024 Jan; 133(1):6-13. PubMed ID: 37702258
[TBL] [Abstract] [Full Text] [Related]
14. Acceptability of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A qualitative evaluation.
Sandell T; Schütze H; Miller A
Health Expect; 2023 Dec; 26(6):2441-2452. PubMed ID: 37583292
[TBL] [Abstract] [Full Text] [Related]
15. Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy.
Tsui JMG; Kehayias CE; Leeman JE; Nguyen PL; Peng L; Yang DD; Moningi S; Martin N; Orio PF; D'Amico AV; Bredfeldt JS; Lee LK; Guthier CV; King MT
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):74-84. PubMed ID: 37517600
[TBL] [Abstract] [Full Text] [Related]
16. An uncertainty-incorporated method for fast beam angle selection in intensity-modulated proton therapy.
Ramar N; Meher SR
J Cancer Res Ther; 2023; 19(3):688-696. PubMed ID: 37470595
[TBL] [Abstract] [Full Text] [Related]
17. The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic prostate cancer.
Joyce DD; Qin X; Sharma V; Boorjian SA; Barocas DA; Dusetzina SB; Moses KA
J Urol; 2023 Sep; 210(3):447-453. PubMed ID: 37341420
[TBL] [Abstract] [Full Text] [Related]
18. A Narrative Synthesis of Literature on the Barriers to Timely Diagnosis and Treatment of cancer in Sub-Saharan Africa.
Mwamba M; Lombe DC; Msadabwe S; Bond V; Simwinga M; Sentoogo Ssemata A; Muhumuza R; Seeley J; Mwaka AD; Aggarwal A
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e537-e548. PubMed ID: 37302880
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
[TBL] [Abstract] [Full Text] [Related]
20. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
[Next]
